Ignite Creation Date:
2025-12-17 @ 7:50 PM
Ignite Modification Date:
2025-12-24 @ 7:32 AM
Study NCT ID:
NCT00733902
Status:
COMPLETED
Last Update Posted:
2021-03-22
First Post:
2008-08-11
Is Possible Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Tanezumab in Osteoarthritis of the Knee
Sponsor:
Pfizer
Organization:
Study Overview
Official Title:
A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTICENTER STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE
Status:
COMPLETED
Status Verified Date:
2021-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Test the efficacy and safety of 3 doses in Osteoarthritis of the knee in patients.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| P3 OA KNEE | OTHER | Alias Study Number | View |